Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
atherosclerosis/protease
Der Link wird in der Zwischenablage gespeichert
Seite 1 von 39 Ergebnisse
Cyanamides useful as reversible inhibitors of cysteine proteases
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
This invention relates to cyanamide compounds useful as reversible inhibitors of the cysteine proteases cathepsins S, K, F, L and B. Certain embodiments described are preferable for inhibition of cathepsin K. The compounds are therefore useful in the treatment of cysteine
Method of treating diseases mediated by cyclic nucleotide pathways with purified stem bromelain protease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
The present invention relates to the use of one of the components of the enzyme mixture bromelain in the treatment of various conditions which are dependent on cyclic nucleotide and other intracellular and/or extracellular pathways.
Work has already been carried out on
Protease-activated receptor 3 and uses thereof
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
This invention relates to nucleic acids, their encoded protease-activated receptor 3 proteins, and screening assays for agonists and antagonists of the protease activated receptor 3 proteins.
BACKGROUND OF THE INVENTION
Thrombin, a coagulation protease generated at sites of
DNA encoding a protease-activated receptor 3
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
This invention relates to nucleic acids, their encoded protease-activated receptor 3 proteins, and screening assays for agonists and antagonists of the protease activated receptor 3 proteins.
BACKGROUND OF THE INVENTION
Thrombin, a coagulation protease generated at sites of
Catalytic monoclonal antibodies with protease activity for selective lysis of protein component of plaques aggregates pathological conditions
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to catalytic monoclonal antibodies, in particular with protease activity, for the selective lysis of the protein component of plaques and aggregates related to pathological conditions.
Alzheimer's Disease
Alzheimer's disease (AD) is a degenerative disease which affects
Regulation of human transmembrane serine protease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
TECHNICAL FIELD OF THE INVENTION
The invention relates to the area of regulation human transmembrane serine protease activity to provide therapeutic effects.
BACKGROUND OF THE INVENTION
Metastasizing cancer cells invade the extracellular matrix using plasma membrane protrusions that contact and
Regulation of human transmembrane serine protease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
TECHNICAL FIELD OF THE INVENTION
The invention relates to the area of regulation human transmembrane serine protease activity to provide therapeutic effects.
BACKGROUND OF THE INVENTION
Metastasizing cancer cells invade the extracellular matrix using plasma membrane protrusions that contact and
Regulation of human transmembrane serine protease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
TECHNICAL FIELD OF THE INVENTION
The invention relates to the area of regulation human transmembrane serine protease activity to provide therapeutic effects.
BACKGROUND OF THE INVENTION
Metastasizing cancer cells invade the extracellular matrix using plasma membrane protrusions that contact and
Nitriles useful as reversible inhibitors of cysteine proteases
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
This invention relates to peptidyl carbamates and related compounds. The compounds are reversible inhibitors of the cysteine proteases cathepsins S, K, F, L and B and certain embodiments described are preferable for inhibition of cathepsin K. The compounds are therefore useful
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD
This disclosure relates to treatment of laminopathies, cellular aging and aging-related conditions, and more particularly to the use of farnesyltransferase inhibitors (FTIs) and other compounds and compositions to treat such conditions. It also relates to methods of identifying agents useful
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD
This disclosure relates to treatment of laminopathies, cellular aging and aging-related conditions, and more particularly to the use of farnesyltransferase inhibitors (FTIs) and other compounds and compositions to treat such conditions. It also relates to methods of identifying agents useful
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD
This disclosure relates to treatment of laminopathies, cellular aging and aging-related conditions, and more particularly to the use of farnesyltransferase inhibitors (FTIs) and other compounds and compositions to treat such conditions. It also relates to methods of identifying agents useful
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD
This disclosure relates to treatment of laminopathies, cellular aging and aging-related conditions, and more particularly to the use of farnesyltransferase inhibitors (FTIs) and other compounds and compositions to treat such conditions. It also relates to methods of identifying agents useful
Serine protease inhibitors-N-substituted derivatives
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases.
BACKGROUND OF THE INVENTION
The serine proteases are a class of enzymes which includes elastase, chymotrypsin, cathepsin G, trypsin and thrombin.
Regulation of human prostasin-like serine protease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a National Stage application of co-pending PCT application PCT/EP01/07116 filed Jun. 22, 2001, which was published in English under PCT Article 21(2) on Dec. 27, 2001, which claims the benefit of U.S. provisional application Ser. No. 60/213,474 filed Jun. 23, 2000 and Ser. No.
Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird
- Arbeitet in 55 Sprachen
- Von der Wissenschaft unterstützte Kräuterkuren
- Kräutererkennung durch Bild
- Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
- Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
- Suchen Sie nach Heilkräutern nach ihrer Wirkung
- Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden
Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen
